Katharina Och
Forschungsgebiet
|
Lebenslauf
Seit 07/2017: Doktorandin in der Klinischen Pharmazie
09/2016 – 06/2017: Apothekerin, Stadt-Apotheke, Heppenheim
07/2016: Approbation als Apothekerin
11/2015 – 04/2016: Praktisches Jahr, University of Florida, Orlando & Translational Research Institute for Metabolism and Diabetes, Orlando (USA)
05/2015 – 10/2015: Praktisches Jahr, Lahn-Apotheke, Marburg
04/2011 – 04/2015: Studium der Pharmazie, Philipps-Universität, Marburg
Publikationen
Manuskripte
Stellbrink HJ, Schaller T, Sturm K, Brockmeyer NH, Potthoff A, Bickel M, Scholten S, Postel N, Jessen A, Müller M, Jäger D, Müller C, Seyfizadeh N, Schöffel S, Ullrich B, Brosi L, Kunz C, Thomas D, Laage R, Hanakam F, Schwab M, Schönborn-Kellenberger O, Mangold M, Och K, Lehr T, Arndt MA, Krauss J. Safety and efficacy of monoclonal antibody therapy in patients with chronic herpes simplex virus-2 genital infections: MATCH-2, a randomized double-blinded, parallel-group phase 2 multi-center trial. Pharmacol Res. 2025;221:107999. Werthner Q, Faehrmann L, Och K, Bragazzi NL, Hug MJ, Stahmeyer J, Burger B, Bauer C, Selzer D, Schwalbe O, May U, Lehr T. Client satisfaction, safety, and insights from a three-season survey on influenza vaccinations delivered at community pharmacies in Germany. Vaccine. 2025;45:126650. Götz KM, Turki AT, Och K, Selzer D, Brossette C, Graf N, Rauch J, Theobald S, Braun Y, Rohm K, Weiler G, Rüdesheim S, Schwab M, Eisenberg L, Pfeifer N, Kiefer S, Schwarz U, Riede C, Smola S, Beelen DW, Kaddu-Mulindwa D, Rissland J, Bittenbring J, Lehr T. Model-based prediction of clinically relevant thrombocytopenia after allogeneic hematopoietic stem cell transplantation. Clin Pharmacol Ther. 2025;117(5):1413-1426. Sager P, Kaiser A, Schumann S, Ludescher B, Niedermaier M, Schmidt I, Och K, Dings C, Lehr T, Brysch W. Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo-controlled phase 2a trial. Lancet Reg Health Eur. 2024;37:100810. Och K, Turki AT, Götz KM, Selzer D, Brossette C, Theobald S, Braun Y, Graf N, Rauch J, Rohm K, Weiler G, Kiefer S, Schwarz U, Eisenberg L, Pfeifer N, Ihle M, Grandjean A, Fix S, Riede C, Rissland J, Smola S, Beelen DW, Kaddu-Mulindwa D, Bittenbring J, Lehr T. A dynamic time‐to‐event model for prediction of acute graft‐versus‐host disease in patients after allogeneic hematopoietic stem cell transplantation. Cancer Med. 2024;13(1):e6833. Dings C, Götz KM, Och K, Sihinevich I, Werthner Q, Smola S, Bliem M, Mahfoud F, Volk T, Kreuer S, Rissland J, Selzer D, Lehr T. Model-based analysis of SARS-CoV-2 infections, hospitalization and outcome in Germany, the federal states and districts. Viruses. 2022;14(10):2114. Weiler G, Schwarz U, Rauch J, Rohm K, Lehr T, Theobald S, Kiefer S, Götz K, Och K, Pfeifer N, Handl L, Smola S, Ihle M, Turki AT, Beelen DW, Rissland J, Bittenbring J, Graf N. XplOit: An Ontology-Based Data Integration Platform Supporting the Development of Predictive Models for Personalized Medicine. Stud Health Technol Inform. 2018;247:21-25. |
Buchkapitel
| G. Weiler, U. Schwarz, J. Rauch, K. Rohm, T. Lehr, S. Theobald, S. Kiefer, K. Götz, K. Och, N. Pfeifer, L. Handl, S. Smola, M. Ihle, A.T. Turki, D.W. Beelen, J. Rissland, J. Bittenbring, N. Graf. "XplOit: An Ontology-Based Data Integration Platform Supporting the Development of Predictive Models for Personalized Medicine" in Building Continents of Knowledge in Oceans of Data: The Future of Co-Created eHealth, Studies in Health Technology and Informatics 2018, Volume 247:21-25. |
Poster
Och K, Bittenbring JT, Lehr T. A pharmacokinetic/pharmacodynamic model of cyclosporine A and its nephrotoxicity in patients after hematopoietic stem cell transplantation. 27th Population Approach Group Europe (PAGE) meeting, 2018, Montreux, Switzerland. Och K, Götz KM, Rauch J, Rohm K, Schwarz U, Theobald S, Braun Y, Kiefer S, Pfeifer N, Handl L, Smola S, Ihle M, Turki A, Rissland J, Bittenbring JT, Graf N, Beelen D, Weiler G, Lehr T. XplOit – Semantic support for predictive modelling in systems medicine. Annual Meeting of the Central European Society for Anticancer Drug Research (CESAR), 2018, Berlin, Germany. |

Kontakt
Katharina Och Klinische Pharmazie T: +49/681/302-70257 |